Literature DB >> 14608113

Polyphenols, inflammatory response, and cancer prevention: chlorination of isoflavones by human neutrophils.

Tracy D'Alessandro1, Jeevan Prasain, M R Benton, Nigel Botting, Ray Moore, Victor Darley-Usmar, Rakesh Patel, Stephen Barnes.   

Abstract

An important aspect of the risk of cancer is the involvement of the inflammatory response. Currently, antiinflammatory agents are used in chemopreventive strategies. For example, aspirin is recommended for the prevention of colon cancer as well as breast and other cancers. The inflammatory response involves the production of cytokines and proinflammatory oxidants such as hypochlorous acid (HOCl) and peroxynitrite (ONO2-) produced by neutrophils and macrophages, respectively. These oxidants react with phenolic tyrosine residues on proteins to form chloro- and nitrotyrosine. Diets rich in polyphenols (green tea catechins, soy isoflavones) have also been shown to be chemopreventive. The aromatic nature of polyphenols makes them potential targets of HOCl and ONO2-. These reactions may create novel pharmacophores at the site of inflammation. Previous studies in the neutrophil-like cell line, differentiated HL-60 cells, demonstrated the formation of chlorinated and nitrated isoflavones. In this study we have examined whether similar reactions occur in freshly isolated human neutrophils. After induction of a respiratory burst with a phorbol ester, isoflavones and their metabolites were identified by liquid chromatography-tandem mass spectrometry and then quantitatively measured by LC-mass spectrometry using multiple-reaction ion monitoring. The data obtained indicate that both chlorinated and nitrated genistein are formed by human neutrophils. The extent of chlorination of genistein was markedly increased by the phorbol ester whereas the low level of nitration of genistein was constitutive and unaffected. These data imply a potential role for modified forms of genistein that would be produced in the inflammatory environment in and around a tumor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14608113     DOI: 10.1093/jn/133.11.3773S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  13 in total

1.  Chemoprevention of esophageal adenocarcinoma.

Authors:  Julian A Abrams
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

2.  Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.

Authors:  Jennifer H Ahn-Jarvis; Steven K Clinton; Elizabeth M Grainger; Kenneth M Riedl; Steven J Schwartz; Mei-Ling T Lee; Raul Cruz-Cano; Gregory S Young; Gregory B Lesinski; Yael Vodovotz
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

Review 3.  Botanicals for age-related diseases: from field to practice.

Authors:  Connie M Weaver; Stephen Barnes; J Michael Wyss; Helen Kim; Dorothy M Morré; D James Morré; James E Simon; Mary Ann Lila; Elsa M Janle; Mario G Ferruzzi
Journal:  Am J Clin Nutr       Date:  2008-02       Impact factor: 7.045

4.  High-resolution mass spectrometry analysis of protein oxidations and resultant loss of function.

Authors:  Stephen Barnes; Erin M Shonsey; Shannon M Eliuk; David Stella; Kerri Barrett; Om P Srivastava; Helen Kim; Matthew B Renfrow
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

Review 5.  The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems.

Authors:  Stephen Barnes; Jeevan Prasain; Tracy D'Alessandro; Ali Arabshahi; Nigel Botting; Mary Ann Lila; George Jackson; Elsa M Janle; Connie M Weaver
Journal:  Food Funct       Date:  2011-05-09       Impact factor: 5.396

Review 6.  Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease.

Authors:  Ana García-Lafuente; Eva Guillamón; Ana Villares; Mauricio A Rostagno; José Alfredo Martínez
Journal:  Inflamm Res       Date:  2009-04-21       Impact factor: 4.575

7.  Research Highlights from the Purdue-UAB Botanicals Research Center for Age Related Diseases.

Authors:  Connie M Weaver; Stephen Barnes; J Michael Wyss; Helen Kim; Dorothy M Morré; D James Morré; James E Simon; Mary Ann Lila; Elsa M Janle; Mario G Ferruzzi
Journal:  Pharm Biol       Date:  2009-08-01       Impact factor: 3.503

8.  Isoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic Disease.

Authors:  Rakesh P Patel; Stephen Barnes
Journal:  PPAR Res       Date:  2011-02-24       Impact factor: 4.964

Review 9.  The effects of extracellular matrix proteins on neutrophil-endothelial interaction--a roadway to multiple therapeutic opportunities.

Authors:  Jagannath Padmanabhan; Anjelica L Gonzalez
Journal:  Yale J Biol Med       Date:  2012-06-25

Review 10.  Therapeutic targeting of replicative immortality.

Authors:  Paul Yaswen; Karen L MacKenzie; W Nicol Keith; Patricia Hentosh; Francis Rodier; Jiyue Zhu; Gary L Firestone; Ander Matheu; Amancio Carnero; Alan Bilsland; Tabetha Sundin; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-04-11       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.